Signup for the www.T0pm@rketgainers.c0m free newsletter, these guys have have been right on the money with all of their picks. They have a special trade alert coming out tomorrow at 9:30am EST. Their last 9:30 AM trade alert went up 64% in just one day. If you want to get an early jump on the fastest moving NASDAQ and OTC stocks signup now. Just google "pennystock101" Best of luck tomorrow.
No Way Out
NVTA is bouncing around $10 per share, which makes the value of the pending merger swap worth between $8.40 and $9.00 per CBMX share - a nice arbitrage return that nobody seems interested in? There is always the risk that the NVTA share price will falter, but the recent earnings were solid and the acquisitions they announced will result in higher near-term growth, so there is as much chance that the NVTA shares advance from here.
Money Street pumping this one today.................Anybody suspects something ?
Best MicroCap, Small Cap and Emerging Stocks to Buy - J Charles Assets
We search for the smart new growing companies to invest in with stock deals to watch in pharmacuetical and digital verticals.
Watching to see if they break-even...
Aegis Capital initiates coverage on CBMX. Price target of $8.10, and points out that even the lowest sales projections make it worth that much.
Enterprise Value to Sales ratio for the group is 2.2; EV/Sales for Combimatrix is .8. On the verge of profitability. No further equity offerings should be required.
In the short-term CBMX does not seem to be like a good trade. have you guys heard of awe.some.stock_s. i started receiving their allerts and so far i am happy.
Beware of GreatDayIsBack2017. He's a boiler room scammer. Whatever scam stock he pumps, will implode.
What's crapppppier CBMX or OMER or RAD? Too close to call?
From $2,238.00 to $6.35. Is there a crappppppppppier stock? When do they close up shop? After another reverse split?
Timber... Might buy at $5.20...
Q2/ 2017 vs Q2/2016. Revenue in Q2/2016 was 3.107M. Looks like they'll do $4.0M in 2017 - that's a 30% increase which is what they have been doing for a while. But gross profit was 54% last year. They are running closer to 60% this year. That will make a big difference. They lost $1.24M last year. Running the figures for 2017, I see where they will lose $350K this year or roughly 12 cents/share.
Anyone else got figures?
Blowout!!! Beat by .07 and beat on revenues! This is finally going to return to above $10 where I will at least break even! Then I'll hold for profits. Very glad us long suffering longs are about to see vindication! Great job management!!!!!!!!!!!!
Still trading at 36 cents before 15 to 1 Reverse Split... Quite the Volume today, 1 million shares traded with about 3 million shares outstanding...
BIG DEAL TO ACQUIRE UP TO 9 MARKETED PRODUCTS IMMINENT = 2000%++ UPSIDE POTENTIAL !!! AQSZF (MC $11 M) is close to profitability and to file 3 NDA and the whole company is valued at ridiculous $11 Million ,this unknown stock is definitely one of the cheapest Biotech in the sector .Stock should be at minimum $2+ right now .
Market Cap :US$ 11 Million Cash $4.1 Million << enough untill mid 2018 Price 0.18
File for CDN approval of Oxcarbazepine XR in 1H 2017
Additional Product Deals in 2017
Partnership for AQS1301 in 2017
Two products launches to date (Tacrolimus IR and Vistitan™)
3 long-acting, transdermal programs in development, on track to file NDA in 2018
Aequus has an expanding product pipeline of drugs in Canada. Revenues and cash flows are increasing and products produce a 50% margin, Edward Karr, Managing ...
Where will this go tomorrow based on latest financial information?
Debating to add a position here, local Orange County, CA investor... Albeit, CBMX has had about 3 Reverse Splits, so not a lot of confidence there... Is this the turning point with a loss under $500K vs. over $1.5 million last year... Cash Flow positive goal in Q4 2017???????? Only 2.9 million shares outstanding... Roll the dice here????????????????????
Earning release May 4. I'm looking for $3.85M in revenue; $4.1 in total expenses for a loss of 250K. With 2.5M shares outstanding, that would be a loss of 10 cents per share. I would sure love to see more revenue, though, which of course would mean more of everything else but loss.